is bpc-157 banned by fda Approval Status: It Approved for Human Use? BPC-157: The Real Reason Why
Description
Headaches: Reported at rates slightly above placebo, headaches can often be attributed to dehydration or rapid dietary changes rather than direct pharmacological effects
Call us today to schedule a consultation or appointment
Thymosin beta therapy primarily reduces inflammation
This means each unit on the syringe holds less peptide, which can be a significant advantage when your research protocol calls for very small, nuanced doses
